Cardinal Bases Fee-For-Service Deals On Customer Profitability Analysis

Cardinal's fee-for-service negotiations with drug manufacturers rely on the wholesaler's analysis of each company's profitability, Exec VP-Pharmaceutical Distribution Mark Parrish said